SCHEMBL6811278

SCHEMBL6811278

Cc1ccccc1CN(Cc1ccccc1)C(=O)c1cc(C=O)ccc1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 3/20 0.43
MAPK1 P28482 1/20 0.43
KLK1 P06870 1/20 0.41
APP P05067 4/20 0.41
PTGER4 P35408 2/20 0.40
PTGER3 P43115 2/20 0.40
PTGER2 P43116 2/20 0.40
FFAR4 Q5NUL3 1/20 0.40
RAF1 P04049 1/20 0.40
MAP2K1 Q02750 1/20 0.40
LMNA P02545 1/20 0.40
SLC1A5 Q15758 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PTGER1 P34995 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929421 0.90 KDM4E (0.54) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL2933284 0.90 TSHR (0.46) KDM4EALDH1A1TSHRMAPK1MAOA
SCHEMBL2928131 0.89 KDM4E (0.47) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL6805058 0.89 KDM4E (0.47) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2928136 0.82 APP (0.47) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2930961 0.81 TSHR (0.52) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL6807414 0.79 SGMS2 (0.52) KDM4EALDH1A1POLBL3MBTL1MAPK1
SCHEMBL2932073 0.79 APP (0.49) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2926924 0.79 PTGER1 (0.51) KDM4EALDH1A1POLBL3MBTL1TSHR
SCHEMBL2932095 0.78 PDK1 (0.51) KDM4EALDH1A1POLBL3MBTL1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6740670-B2 SUCH AS 5-(((3-(N-METHYL-N-PHENYLAMINO)CARBONYL-4-(PHENYL-METHOXY)) -PHENYL)METHYLENE)-4-OXO-2-THIOXO-3-THIAZOLIDINE-ACETIC ACID OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2004-05-25 US disclosed
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent CYP3A7, TAS2R7, OXSR1 KDM4E 3752/4885ALDH1A1 2527/4885POLB 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.